Convergent Dental Inc. (Boston, Massachusettes), a privately held dental device company, today announced that David Garabedian has joined the team as vice president of marketing. In addition to marketing Convergent Dental’s flagship product, Solea, the first FDA-cleared CO2 9.3 micron dental laser for hard, soft, and osseous tissue procedures, Garabedian will be in charge of elevating the company’s innovative technologies from conceptual ideas to commercialized products.
RELATED: Solea's impact on chair time and revenue | By David Fantarella, DMD
“It is rare to find an opportunity to lead the marketing efforts for a rapidly growing medical device company that combines such compelling technology with the ability to solve such a clear and relatable clinical problem,” said Garabedian. “I joined Convergent Dental because they are positioned to dramatically influence a new way to manage oral health and I am delighted to be entrusted with helping the company accelerate the next phase of exceptional growth.”
Garabedian brings more than 15 years of medical device marketing experience to Convergent Dental and has a deep-rooted passion for building high-performing teams, developing global brands, and introducing breakthrough technologies with companies like Philips, C.R. Bard, Orthofix Orthopedics, and Boston Scientific. He has a rich understanding of product positioning, branding, and new product go-to-market planning, as well as a proven track record of delivering stable revenue growth for endoscopy, orthopedics, atrial fibrillation, and emergency care products.
“The future success of Convergent Dental is highly dependent on our employees’ passion for excellence,” said Michael Cataldo, CEO of Convergent Dental. “Our team is thrilled to have David on board, as his expertise in product marketing will accelerate the growth of Solea and all of our future innovations.”
Source: Convergent Dental press release, 12 January 2016.
